Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomics.

sirolimus - Generic mfg.

AVTX-006 - Avalo Therap

http://www.ncbi.nlm.nih.gov/pubmed/38916794

Jiangyujing Bian; Jiaqi Dou; Jie Pan; Kai Fan; Yewen Sun; Yueyuan Wang; Yunli Yu

Jun 25, 2024